SAN FRANCISCO, CA
Allocation by class
Portfolio Concentration
Top 3 weight
73.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 22.50M
Full voting authority
0.00
shares
Joint voting authority
22.50M
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc.OTR | Common Stock | 3.18M | SH | $52.32M 37.00% | 0.00 | 3.18M | 0.00 |
Century Therapeutics, Inc.OTR | Common Stock | 12.17M | SH | $27.50M 19.44% | 0.00 | 12.17M | 0.00 |
Lenz Therapeutics, Inc.OTR | Common Stock | 2.66M | SH | $24.31M 17.19% | 0.00 | 2.66M | 0.00 |
Jade Biosciences, Inc.OTR | Common Stock | 1.53M | SH | $21.44M 15.16% | 0.00 | 1.53M | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 542.63K | SH | $7.09M 5.01% | 0.00 | 542.63K | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 148.83K | SH | $7.08M 5.01% | 0.00 | 148.83K | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $1.23M 0.87% | 0.00 | 2.01M | 0.00 |
Tempest Therapeutics, Inc.OTR | Common Stock | 269.77K | SH | $442.4K 0.31% | 0.00 | 269.77K | 0.00 |